Zevra therapeutics to participate at the guggenheim securities healthcare innovation conference on wed, nov. 13

Celebration, fla., nov. 06, 2024 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company), a commercial-stage company focused on addressing unmet needs for the treatment of rare diseases, today announced that neil f. mcfarlane, president and chief executive office of zevra, will participate in a fireside chat at the guggenheim securities healthcare innovation conference virtual on wednesday, nov. 13, 2024, at 4 p.m. et. additionally, management will be available for one-on-one meetings with registered attendees.
ZVRA Ratings Summary
ZVRA Quant Ranking